重症脑血管病临床研究20年

doi:10.3969/j.issn.1673-5765.2025.05.004

摘要/Abstract

摘要： 重症脑血管病是神经重症医学专业最常见的疾病种类。重症脑血管病领域的研究为此类疾病的临床诊疗奠定了基础。近20年来，重症脑血管病诊疗领域的重点、热点问题有前循环大梗死核心和后循环缺血性卒中的再灌注治疗，以及再灌注治疗后的血压管理，大面积半球性脑梗死去骨瓣减压术，缺血性卒中抗水肿治疗，脑出血的微创手术、药物止血、逆转抗凝治疗，脑出血急性期血压管理，动脉瘤性蛛网膜下腔出血患者破裂动脉瘤的处理，迟发性脑缺血和颅内压增高的监测及处理等。本文概述国内外学者围绕这些问题开展的重要临床研究，探讨其带来的启发，总结重症脑血管病临床研究的发展规律并展望未来研究的趋势。

关键词: 神经病学; 重症医学; 脑血管病; 临床研究; 缺血性卒中; 脑出血; 蛛网膜下腔出血

Abstract: Severe cerebrovascular disease is the most common type of disease in neurocritical care medicine. Clinical studies in this domain have laid the foundation for clinical practice. Over the past two decades, key and hot topics in the diagnosis and treatment of severe cerebrovascular disease have included: endovascular thrombectomy for anterior circulation stroke with large infarct cores and for posterior circulation ischemic stroke, blood pressure management after reperfusion therapy, decompressive craniectomy for large hemispheric infarction, anti-edema therapy for ischemic stroke, minimally invasive and medical hemostatic treatment for intracerebral hemorrhage, reversal of anticoagulation therapy, blood pressure management during the acute phase of intracerebral hemorrhage, management of ruptured aneurysms in aneurysmal subarachnoid hemorrhage, and monitoring and treatment of delayed cerebral ischemia and elevated intracranial pressure. Addressing these issues, this article outlines key clinical studies conducted by domestic and international scholars, discusses the inspirations drawn from these studies. Based on the summarized clinical research, researchers outline the future research trends in this area.

Key words: Neurology; Critical care medicine; Cerebrovascular disease; Clinical trial; Ischemic stroke; Intracerebral hemorrhage; Subarachnoid hemorrhage

中图分类号:

张哲, 郑丽娜, 杨中华, 刘丽萍. 重症脑血管病临床研究20年[J]. 中国卒中杂志, 2025, 20(5): 555-565.

ZHANG Zhe, ZHENG Li’na, YANG Zhonghua, LIU Liping. Clinical Studies of Severe Cerebrovascular Disease in Recent 20 Years[J]. Chinese Journal of Stroke, 2025, 20(5): 555-565.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://www.chinastroke.org.cn/CN/10.3969/j.issn.1673-5765.2025.05.004

https://www.chinastroke.org.cn/CN/Y2025/V20/I5/555

参考文献

[1] NOGUEIRA R G，JADHAV A P，HAUSSEN D C，et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct[J]. N Engl J Med，2018，378（1）：11-21.
[2] JOVIN T G，CHAMORRO A，COBO E，et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med，2015，372（24）：2296-2306.
[3] BERKHEMER O A，FRANSEN P S S，BEUMER D，et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med，2015，372（1）：11-20.
[4] GOYAL M，DEMCHUK A M，MENON B K，et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med，2015，372（11）：1019-1030.
[5] SAVER J L，GOYAL M，BONAFE A，et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med，2015，372（24）：2285-2295.
[6] CAMPBELL B C V，MITCHELL P J，KLEINIG T J，et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med，2015，372（11）：1009-1018.
[7] ALBERS G W，MARKS M P，KEMP S，et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging[J]. N Engl J Med，2018，378（8）：708-718.
[8] PSYCHOGIOS M，BREHM A，RIBO M，et al. Endovascular treatment for stroke due to occlusion of medium or distal vessels[J]. N Engl J Med，2025，392（14）：1374-1384.
[9] YOSHIMURA S，SAKAI N，YAMAGAMI H，et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med，2022，386（14）：1303-1313.
[10] SARRAJ A，HASSAN A E，ABRAHAM M G，et al. Trial of endovascular thrombectomy for large ischemic strokes[J]. N Engl J Med，2023，388（14）：1259-1271.
[11] HUO X C，MA G T，TONG X，et al. Trial of endovascular therapy for acute ischemic stroke with large infarct[J]. N Engl J Med，2023，388（14）：1272-1283.
[12] COSTALAT V，JOVIN T G，ALBUCHER J F，et al. Trial of thrombectomy for stroke with a large infarct of unrestricted size[J]. N Engl J Med，2024，390（18）：1677-1689.
[13] The Writing Committee for the TESLA Investigators. Thrombectomy for stroke with large infarct on noncontrast CT：the TESLA randomized clinical trial[J]. JAMA，2024，332（16）：1355-1366.
[14] BENDSZUS M，FIEHLER J，SUBTIL F，et al. Endovascular thrombectomy for acute ischaemic stroke with established large infarct：multicentre，open-label，randomised trial[J]. Lancet，2023，402（10414）：1753-1763.
[15] CHEN H W，LEE J S，MICHEL P，et al. Endovascular stroke thrombectomy for patients with large ischemic core：a review[J]. JAMA Neurol，2024，81（10）：
1085-1093.
[16] LIU X F，DAI Q L，YE R D，et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion（BEST）：an open-label，randomised controlled trial[J]. Lancet Neurol，2020，19（2）：115-122.
[17] LANGEZAAL L C M，VAN DER HOEVEN E J R J，MONT’ALVERNE F J A，et al. Endovascular therapy for stroke due to basilar-artery occlusion[J]. N Engl J Med，2021，384（20）：1910-1920.
[18] TAO C R，NOGUEIRA R G，ZHU Y Y，et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1361-1372.
[19] JOVIN T G，LI C H，WU L F，et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1373-1384.
[20] ANDERSON C S，HUANG Y N，LINDLEY R I，et al. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke（ENCHANTED）：an international，randomised，open-label，blinded-endpoint，phase 3 trial[J]. Lancet，2019，393（10174）：877-888.
[21] MAZIGHI M，RICHARD S，LAPERGUE B，et al. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke（BP-TARGET）：a multicentre，open-label，randomised controlled trial[J]. Lancet Neurol，2021，20（4）：265-274.
[22] MISTRY E A，HART K W，DAVIS L T，et al. Blood pressure management after endovascular therapy for acute ischemic stroke：the BEST-Ⅱ randomized clinical trial[J]. JAMA，2023，330（9）：821-831.
[23] YANG P F，SONG L L，ZHANG Y W，et al. Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke（ENCHANTED2/MT）：a multicentre，open-label，blinded-endpoint，randomised controlled trial[J]. Lancet，2022，400（10363）：1585-1596.
[24] NAM H S，KIM Y D，HEO J，et al. Intensive vs. conventional blood pressure lowering after endovascular thrombectomy in acute ischemic stroke：the OPTIMAL-BP randomized clinical trial[J]. JAMA，2023，330（9）：832-842.
[25] CHEN H B，SU Y Y，HE Y B，et al. Controlling blood pressure under transcranial Doppler guidance after endovascular treatment in patients with acute ischemic stroke[J]. Cerebrovasc Dis，2020，49（2）：160-169.
[26] PETERSEN N H，SILVERMAN A，STRANDER S M，et al. Fixed compared with autoregulation-oriented blood pressure thresholds after mechanical thrombectomy for ischemic stroke[J]. Stroke，2020，51（3）：914-921.
[27] ZHANG Z，PU Y H，YU L，et al. Deviation from personalized blood pressure targets correlates with worse outcome after successful recanalization[J/OL]. J Am Heart Assoc，2024，13（7）：e033633[2025-05-01]. https://doi.org/10.1161/JAHA.123.033633.
[28] VAHEDI K，VICAUT E，MATEO J，et al. Sequential-design，multicenter，randomized，controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction（DECIMAL trial）[J]. Stroke，2007，38（9）：2506-2517.
[29] JÜTTLER E，SCHWAB S，SCHMIEDEK P，et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery（DESTINY）：a randomized，controlled trial[J]. Stroke，2007，38（9）：2518-2525.
[30] HOFMEIJER J，KAPPELLE L J，ALGRA A，et al. Surgical decompression for space-occupying cerebral infarction [the hemicraniectomy after middle cerebral artery infarction with life-threatening edema trial （HAMLET）]：a multicentre，open，randomised trial[J]. Lancet Neurol，2009，8（4）：326-333.
[31] SLEZINS J，KERIS V，BRICIS R，et al. Preliminary results of randomized controlled study on decompressive craniectomy in treatment of malignant middle cerebral artery stroke[J]. Medicina（Kaunas），2012，48（10）：521-524.
[32] ZHAO J W，SU Y Y，ZHANG Y，et al. Decompressive hemicraniectomy in malignant middle cerebral artery infarct：a randomized controlled trial enrolling patients up to 80 years old[J]. Neurocrit Care，2012，17（2）：161-171.
[33] FRANK J I，SCHUMM L P，WROBLEWSKI K，et al. Hemicraniectomy and durotomy upon deterioration from infarction-related swelling trial：randomized pilot clinical trial[J]. Stroke，2014，45（3）：781-787.
[34] JÜTTLER E，UNTERBERG A，WOITZIK J，et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke[J]. N Engl J Med，2014，370（12）：1091-1100.
[35] VAHEDI K，HOFMEIJER J，JUETTLER E，et al. Early decompressive surgery in malignant infarction of the middle cerebral artery：a pooled analysis of three randomised controlled trials[J]. Lancet Neurol，2007，6（3）：215-222.
[36] LIN J，FRONTERA J A. Decompressive hemicraniectomy for large hemispheric strokes[J]. Stroke，2021，52（4）：1500-1510.
[37] DASENBROCK H H，ROBERTSON F C，VAITKEVICIUS H，et al. Timing of decompressive hemicraniectomy for stroke：a nationwide inpatient sample analysis[J]. Stroke，2017，48（3）：704-711.
[38] STOKUM J A，SHIM B，NEGOITA S，et al. Cation flux through SUR1-TRPM4 and NCX1 in astrocyte endfeet induces water influx through AQP4 and brain swelling after ischemic stroke[J/OL]. Sci Signal，2023，16（788）：eadd6364[2025-05-01]. https://doi.org/10.1126/scisignal.add6364.
[39] SHETH K N，ALBERS G W，SAVER J L，et al. Intravenous glibenclamide for cerebral oedema after large hemispheric stroke（CHARM）：a phase 3，double-blind，placebo-controlled，randomised trial[J]. Lancet Neurol，2024，23（12）：1205-1213.
[40] PIIRONEN K，TIAINEN M，MUSTANOJA S，et al. Mild hypothermia after intravenous thrombolysis in patients with acute stroke：a randomized clinical trial[J]. Stroke，2014，45（2）：486-491.
[41] SU Y Y，FAN L L，ZHANG Y Z，et al. Improved neurological outcome with mild hypothermia in surviving patients with massive cerebral hemispheric infarction[J]. Stroke，2016，47（2）：457-463.
[42] FAN L L，SU Y Y，ZHANG Y，et al. Decompressive craniectomy combined with mild hypothermia in patients with large hemispheric infarction：a randomized controlled trial[J/OL]. BMC Neurol，2021，21（1）：114[2025-05-01]. https://doi.org/10.1186/s12883-021-02142-7.
[43] NEUGEBAUER H，SCHNEIDER H，BÖSEL J，et al. Outcomes of hypothermia in addition to decompressive hemicraniectomy in treatment of malignant middle cerebral artery stroke：a randomized clinical trial[J]. JAMA Neurol，2019，76（5）：571-579.
[44] MENDELOW A D，GREGSON B A，FERNANDES H M，et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage（STICH）：a randomised trial[J]. Lancet，2005，365（9457）：387-397.
[45] MENDELOW A D，GREGSON B A，ROWAN E N，et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral haematomas（STICH Ⅱ）：a randomised trial[J]. Lancet，2013，382（9890）：397-408.
[46] HANLEY D F，THOMPSON R E，ROSENBLUM M，et al. Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation（MISTIE Ⅲ）：a randomised，controlled，open-label，blinded endpoint phase 3 trial[J]. Lancet，2019，393（10175）：1021-1032.
[47] WANG W Z，JIANG B，LIU H M，et al. Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage：results from a randomized clinical trial in China[J]. Int J Stroke，2009，4（1）：11-16.
[48] VESPA P，HANLEY D，BETZ J，et al. ICES（intraoperative stereotactic computed tomography-guided endoscopic surgery）for brain hemorrhage：a multicenter randomized controlled trial[J]. Stroke，2016，47（11）：2749-2755.
[49] PRADILLA G，RATCLIFF J J，HALL A J，et al. Trial of early minimally invasive removal of intracerebral hemorrhage[J]. N Engl J Med，2024，390（14）：1277-1289.
[50] MAYER S A，BRUN N C，BEGTRUP K，et al. Efficacy and safety of recombinant activated factor Ⅶ for acute intracerebral hemorrhage[J]. N Engl J Med，2008，358（20）：2127-2137.
[51] SPRIGG N，FLAHERTY K，APPLETON J P，et al. Tranexamic acid for hyperacute primary intracerebral haemorrhage（TICH-2）：an international randomised，placebo-controlled，phase 3 superiority trial[J]. Lancet，2018，391（10135）：2107-2115.
[52] YASSI N，ZHAO H，CHURILOV L，et al. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset（STOP-MSU）：an international，double-blind，randomised，phase 2 trial[J]. Lancet Neurol，2024，23（6）：577-587.
[53] LIU J Y，NIE X M，GU H Q，et al. Tranexamic acid for acute intracerebral haemorrhage growth based on imaging assessment（TRAIGE）：a multicentre，randomised，placebo-controlled trial[J]. Stroke Vasc Neurol，2021，6（2）：160-169.
[54] SARODE R，MILLING T J，JR REFAAI M A，et al. Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding：a randomized，plasma-controlled，phase Ⅲb study[J]. Circulation，2013，128（11）：1234-1243.
[55] STEINER T，POLI S，GRIEBE M，et al. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists（INCH）：a randomised trial[J]. Lancet Neurol，2016，15（6）：566-573.
[56] ANDERSON C S，HEELEY E，HUANG Y N，et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage[J]. N Engl J Med，2013，368（25）：2355-2365.
[57] QURESHI A I，PALESCH Y Y，BARSAN W G，et al. Intensive blood-pressure lowering in patients with acute cerebral hemorrhage[J]. N Engl J Med，2016，375（11）：1033-1043.
[58] MA L，HU X，SONG L L，et al. The third intensive care bundle with blood pressure reduction in acute cerebral haemorrhage trial（INTERACT3）：an international，stepped wedge cluster randomised controlled trial[J]. Lancet，2023，402（10395）：27-40.
[59] MOLYNEUX A J，KERR R S C，YU L M，et al. International subarachnoid aneurysm trial（ISAT）of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms：a randomised comparison of effects on survival，dependency，seizures，rebleeding，subgroups，and aneurysm occlusion[J]. Lancet，2005，366（9488）：809-817.
[60] XIA Z W，LIU X M，WANG J Y，et al. Coiling is not superior to clipping in patients with high-grade aneurysmal subarachnoid hemorrhage：systematic review and meta-analysis[J/OL]. World Neurosurg，2017，98：411-420[2025-05-01]. https://doi.org/10.1016/j.wneu.2016.11.032.
[61] ZHAO B，TAN X，YANG H，et al. Endovascular coiling versus surgical clipping for poor-grade ruptured intracranial aneurysms：postoperative complications and clinical outcome in a multicenter poor-grade aneurysm study[J]. AJNR Am J Neuroradiol，2016，37（5）：873-878.
[62] WICKERING E，GASPARD N，ZAFAR S，et al. Automation of classical QEEG trending methods for early detection of delayed cerebral ischemia：more work to do[J]. J Clin Neurophysiol，2016，33（3）：227-234.
[63] ROSENTHAL E S，BISWAL S，ZAFAR S F，et al. Continuous electroencephalography predicts delayed cerebral ischemia after subarachnoid hemorrhage：a prospective study of diagnostic accuracy[J]. Ann Neurol，2018，83（5）：958-969.
[64] CHEN H Y，ELMER J，ZAFAR S F，et al. Combining transcranial Doppler and EEG data to predict delayed cerebral ischemia after subarachnoid hemorrhage[J/OL]. Neurology，2022，98（5）：e459-e469[2025-05-01]. https://doi.org/10.1212/WNL.0000000000013126.
[65] AL-TAMIMI Y Z，BHARGAVA D，FELTBOWER R G，et al. Lumbar drainage of cerebrospinal fluid after aneurysmal subarachnoid hemorrhage：a prospective，randomized，controlled trial（LUMAS）[J]. Stroke，2012，43（3）：677-682.
[66] WOLF S，MIELKE D，BARNER C，et al. Effectiveness of lumbar cerebrospinal fluid drain among patients with aneurysmal subarachnoid hemorrhage：a randomized clinical trial[J]. JAMA Neurol，2023，80（8）：833-842.
[67] MACDONALD R L，HIGASHIDA R T，KELLER E，et al. Clazosentan，an endothelin receptor antagonist，in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping：a randomised，double-blind，placebo-controlled phase 3 trial（CONSCIOUS-2）[J]. Lancet Neurol，2011，10（7）：618-625.
[68] MACDONALD R L，HIGASHIDA R T，KELLER E，et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling[J]. Stroke，2012，43（6）：1463-1469.
[69] WONG G K C，POON W S，CHAN M T V，et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage（IMASH）：a randomized，double-blinded，placebo-controlled，multicenter phase Ⅲ trial[J]. Stroke，2010，41（5）：921-926.
[70] DORHOUT MEES S M，ALGRA A，VANDERTOP W P，et al. Magnesium for aneurysmal subarachnoid haemorrhage（MASH-2）：a randomised placebo-controlled trial[J]. Lancet，2012，380（9836）：44-49.
[71] MUENCH E，HORN P，BAUHUF C，et al. Effects of hypervolemia and hypertension on regional cerebral blood flow，intracranial pressure，and brain tissue oxygenation after subarachnoid hemorrhage[J]. Crit Care Med，2007，35（8）：1844-1851.
[72] GATHIER C S，DANKBAAR J W，VAN DER JAGT M，et al. Effects of induced hypertension on cerebral perfusion in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage：a randomized clinical trial[J]. Stroke，2015，46（11）：3277-3281.
[73] GATHIER C S，VAN DEN BERGH W M，VAN DER JAGT M，et al. Induced hypertension for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage：a randomized clinical trial[J]. Stroke，2018，49（1）：76-83.
[74] ABULHASAN Y B，ORTIZ JIMENEZ J，TEITELBAUM J，et al. Milrinone for refractory cerebral vasospasm with delayed cerebral ischemia[J]. J Neurosurg，2020，134（3）：971-982.
[75] WEBB A，KOLENDA J，MARTIN K，et al. The effect of intraventricular administration of nicardipine on mean cerebral blood flow velocity measured by transcranial Doppler in the treatment of vasospasm following aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care，2010，12（2）：159-164.
[76] BOMBARDIERI A M，ALBERS G W，RODRIGUEZ S，et al. Percutaneous cervical sympathetic block to treat cerebral vasospasm and delayed cerebral ischemia：a review of the evidence[J]. J Neurointerv Surg，2023，15（12）：1212-1217.
[77] AL-RAWI P G，TSENG M Y，RICHARDS H K，et al. Hypertonic saline in patients with poor-grade subarachnoid hemorrhage improves cerebral blood flow，brain tissue oxygen，and pH[J]. Stroke，2010，41（1）：122-128.
[78] FENG X B，ZHANG T Y，WANG N，et al. Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage：a randomised，double-blind，placebo-controlled clinical trial[J]. Stroke Vasc Neurol，2024，9（5）：530-540.